Waters Corporation (WAT)

New York Stock Exchange:
WAT
| Latest update: Mar 1, 2026, 6:31 PM

Stock events for Waters Corp. (WAT)

Waters Corp. stock has been influenced by Q3 earnings exceeding estimates, the release of fourth-quarter and full-year 2024 financial results, and raised full-year 2025 sales growth and EPS guidance. A proposed merger with the biosciences & diagnostics unit of Becton Dickinson led to shareholder lawsuits. Waters' stock performance has seen a decline, with a 52-week range between $275.05 and $417.10, and a closing stock price of $381.29 as of February 6, 2026.

Demand Seasonality affecting Waters Corp.’s stock price

Waters experienced a return to revenue growth across all end markets in the second half of 2024, with China showing positive growth in the fourth quarter of 2024. India has been identified as a fast-growing end market. Demand is influenced by new product launches, market recoveries in specific regions, and ongoing service needs, rather than a strictly seasonal pattern.

Overview of Waters Corp.’s business

Waters Corporation is a global leader in analytical instruments and software, specializing in workflow solutions involving liquid chromatography (LC), mass spectrometry (MS), laboratory informatics, and rheometry. Its products and services are utilized across diverse industries for research and development, quality assurance, and various laboratory functions.

WAT’s Geographic footprint

Waters Corporation has a significant global presence, operating directly in over 35 countries and serving customers in more than 100 countries. The company maintains primary manufacturing facilities in 9 locations across the United States and 11 international locations, including key regions such as Europe, Asia, and the Americas. Sales in Asia, the Americas, and Europe all saw growth in the fourth quarter of 2024.

WAT Corporate Image Assessment

Waters Corporation has maintained a strong brand reputation, particularly in its service and customer satisfaction, with its service team recognized for delivering the highest service satisfaction scores. The company leads the industry in net promoter scores and has consistently delivered top-tier value to shareholders. However, the proposed merger with BD Biosciences & Diagnostics has led to shareholder lawsuits, which could potentially impact the company's reputation.

Ownership

Waters Corporation's ownership is predominantly institutional, with approximately 53.56% to 94.01% of the company's stock owned by institutional investors. Insiders own about 0.13%, and public companies and individual investors hold the remaining 46.31% to 28.38%. Major institutional shareholders include Vanguard Group Inc., BlackRock, Inc., and Fundsmith LLP.

Expert AI

Show me the sentiment for Waters Corp.
What's the latest sentiment for Waters Corp.?

Price Chart

$319.38

1.07%
(1 month)

Top Shareholders

The Vanguard Group, Inc.
12.56%
BlackRock, Inc.
9.12%
The Eighth Wonder Foundation
7.90%
State Street Corp.
4.51%
Sun Life Financial, Inc.
4.41%
AllianceBernstein LP
3.47%
Geode Holdings Trust
2.68%
Mawer Investment Management Ltd.
2.18%

Trade Ideas for WAT

Today

Sentiment for WAT

News
Social

Buzz Talk for WAT

Today

Social Media

FAQ

What is the current stock price of Waters Corp.?

As of the latest update, Waters Corp.'s stock is trading at $319.38 per share.

What’s happening with Waters Corp. stock today?

Today, Waters Corp. stock is down by -1.07%, possibly due to news.

What is the market sentiment around Waters Corp. stock?

Current sentiment around Waters Corp. stock is negative, based on recent news, trading volume, and analyst opinions.

Is Waters Corp.'s stock price growing?

Over the past month, Waters Corp.'s stock price has decreased by -1.07%.

How can I buy Waters Corp. stock?

You can buy Waters Corp. stock through any brokerage platform, such as e.g., Robinhood, Fidelity, E*TRADE, by searching for the ticker symbol WAT

Who are the major shareholders of Waters Corp. stock?

Major shareholders of Waters Corp. include institutions such as The Vanguard Group, Inc. (12.56%), BlackRock, Inc. (9.12%), The Eighth Wonder Foundation (7.90%) ... , according to the latest filings.